Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Auxly Cannabis Group Inc T.XLY

Alternate Symbol(s):  CBWTF

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company also conducts wholesale bulk sales of dried cannabis to various licensed producers in Canada. Its subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., and Auxly Leamington Inc. The Company’s primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing and conducts the Company’s primary dried flower and pre-roll manufacturing.


TSX:XLY - Post by User

Bullboard Posts
Comment by longonMJon Nov 08, 2018 6:00pm
75 Views
Post# 28947045

RE:Don't forget Auxly's $3.00 Target Boyzzz :)

RE:Don't forget Auxly's $3.00 Target Boyzzz :)Why would you even bother to post a news release and price target from 7 months ago which is like a lifetime in the cannabis amrketplace.

Clearly evident by the fact that the company name has already changed and is no longer Cannabis Wheaton as they have started to move away from the pure streaming model that they initially started out on.  Any bets that a good chunk of the $115M is already spent with still not much to show for it, except for Chuck having a bigger smile on his face and gaining more weight.    Grrrr......................

1hot-techwoman wrote: After completing a new $115 million financing round, Cannabis Wheaton Income Corp. (TSXV:CBW) is now sitting on a huge pile of cash, says analyst Greg McLeish of Mackie Research, who on Tuesday maintained his Buy recommendation and price target of $3.00. May was a busy month for Cannabis Wheaton, which closed on the acquisition of late-stage Licensed Dealer Dosecann Inc., announced an exclusive license for Denver-based Dixie Brands product branding and IP in Canada and closed on a $115 bought deal led by BMO Markets. The financing, to be used for capital expenditures and capacity expansion, brings the companys pro-forma cash position up to $315 million, according to McLeish, who says that CBW is well-positioned for growth in both the medical and recreational cannabis markets. CBWs model allows it to access cannabis production from growing collection of diverse partners, enhancing its position to participate in anticipated provincial distribution channels, says McLeish in an update to clients. Through existing agreements, the company has locked up more than 100,000 kilograms of funded production, positioning it as one of the leading suppliers for both medical and recreational cannabis. McLeish also notes that on June 1, the government of Saskatchewan announced the operators of the provinces 51 cannabis retail store permits, choosing CBWs Kolab Project Inc. to operate a retail location in Lloydminster. The analysts updated forecast has CBW producing a $22.0 million EBITDA loss on revenue of $7.3 million in 2018 and EBITDA of $35.2 million on a topline of $165.3 million in 2019. McLeishs $3.00 target is arrived at by applying a 12x EV/EBITDA multiple to his 2020 estimate and applying a 15 per cent discount rate.


Bullboard Posts